Jérémy Abitbol

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Few large-scale follow-up studies are reported on routine implant treatment. PURPOSE To report retrospective data on early inflammatory and early implant failures in a large number of routine patients at one private referral clinic. MATERIALS AND METHODS A total of 1017 patients were consecutively provided with 3082 implants with an anodized(More)
BACKGROUND Few large-scale follow-up studies are reported on routine implant treatment. PURPOSE To report retrospective data on peri-implantitis and overall implant failures at one private referral clinic (effectiveness study). MATERIALS AND METHODS A total of 1017 patients were consecutively provided with 3082 implants with an anodized surface during(More)
The efficacy and safety of the peripheral kappa agonist fedotozine was evaluated in a double-blind, multicenter study involving 238 patients with the irritable bowel syndrome. After a two-week washout, patients were assigned to one of four groups to receive either placebo or fedotozine three times a day at doses of 3.5, 15, or 30 mg for six weeks. Patient(More)
  • 1